nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—SHMT2—Trans-sulfuration and one carbon metabolism—DNMT3L—testicular cancer	0.0376	0.113	CbGpPWpGaD
Glycine—SLC6A9—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.0229	0.0692	CbGpPWpGaD
Glycine—SLC6A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.0229	0.0692	CbGpPWpGaD
Glycine—SHMT1—Trans-sulfuration and one carbon metabolism—DNMT3L—testicular cancer	0.0222	0.0669	CbGpPWpGaD
Glycine—GSS—Trans-sulfuration and one carbon metabolism—DNMT3L—testicular cancer	0.0216	0.0652	CbGpPWpGaD
Glycine—Fluid overload—Carboplatin—testicular cancer	0.0167	0.0742	CcSEcCtD
Glycine—SLC6A5—NRF2 pathway—SLC2A6—testicular cancer	0.0165	0.0499	CbGpPWpGaD
Glycine—SLC6A9—NRF2 pathway—SLC2A6—testicular cancer	0.0165	0.0499	CbGpPWpGaD
Glycine—PIPOX—seminal vesicle—testicular cancer	0.0144	0.0339	CbGeAlD
Glycine—GPR18—gonad—testicular cancer	0.0144	0.0338	CbGeAlD
Glycine—GCAT—seminal vesicle—testicular cancer	0.014	0.0328	CbGeAlD
Glycine—SLC32A1—testis—testicular cancer	0.0123	0.029	CbGeAlD
Glycine—ALAS1—seminal vesicle—testicular cancer	0.0123	0.0288	CbGeAlD
Glycine—AGXT2—gonad—testicular cancer	0.0119	0.028	CbGeAlD
Glycine—GRIN3B—testis—testicular cancer	0.0119	0.028	CbGeAlD
Glycine—SLC6A9—testis—testicular cancer	0.0119	0.028	CbGeAlD
Glycine—GARS—embryo—testicular cancer	0.0119	0.0279	CbGeAlD
Glycine—ALAS2—testis—testicular cancer	0.0112	0.0263	CbGeAlD
Glycine—GARS—seminal vesicle—testicular cancer	0.0112	0.0262	CbGeAlD
Glycine—GCSH—female gonad—testicular cancer	0.0109	0.0257	CbGeAlD
Glycine—SLC6A9—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.0104	0.0314	CbGpPWpGaD
Glycine—SLC6A5—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.0104	0.0314	CbGpPWpGaD
Glycine—GSS—Glutathione conjugation—HPGDS—testicular cancer	0.0104	0.0312	CbGpPWpGaD
Glycine—GPR18—testis—testicular cancer	0.0104	0.0243	CbGeAlD
Glycine—Diuresis—Cisplatin—testicular cancer	0.00984	0.0437	CcSEcCtD
Glycine—GCSH—testis—testicular cancer	0.0097	0.0228	CbGeAlD
Glycine—SHMT1—Podofilox—Etoposide—testicular cancer	0.00934	0.539	CbGdCrCtD
Glycine—Blindness transient—Methotrexate—testicular cancer	0.00917	0.0407	CcSEcCtD
Glycine—Salivation—Ifosfamide—testicular cancer	0.00913	0.0405	CcSEcCtD
Glycine—SLC32A1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00887	0.0267	CbGpPWpGaD
Glycine—SHMT1—seminal vesicle—testicular cancer	0.00884	0.0208	CbGeAlD
Glycine—SLC6A9—lymph node—testicular cancer	0.00863	0.0203	CbGeAlD
Glycine—AGXT2—testis—testicular cancer	0.0086	0.0202	CbGeAlD
Glycine—PIPOX—female gonad—testicular cancer	0.00846	0.0199	CbGeAlD
Glycine—GCAT—female gonad—testicular cancer	0.00821	0.0193	CbGeAlD
Glycine—GARS—gonad—testicular cancer	0.00806	0.0189	CbGeAlD
Glycine—GLDC—testis—testicular cancer	0.00804	0.0189	CbGeAlD
Glycine—GLYATL1—Phase II conjugation—HPGDS—testicular cancer	0.00802	0.0242	CbGpPWpGaD
Glycine—GLYATL2—Phase II conjugation—HPGDS—testicular cancer	0.00802	0.0242	CbGpPWpGaD
Glycine—GLYAT—Phase II conjugation—HPGDS—testicular cancer	0.00802	0.0242	CbGpPWpGaD
Glycine—SHMT1—Vincristine—Vinblastine—testicular cancer	0.00799	0.461	CbGdCrCtD
Glycine—GATM—gonad—testicular cancer	0.00765	0.018	CbGeAlD
Glycine—PIPOX—testis—testicular cancer	0.0075	0.0176	CbGeAlD
Glycine—GPR18—lymph node—testicular cancer	0.0075	0.0176	CbGeAlD
Glycine—GCAT—testis—testicular cancer	0.00728	0.0171	CbGeAlD
Glycine—ALAS1—female gonad—testicular cancer	0.00719	0.0169	CbGeAlD
Glycine—GCSH—lymph node—testicular cancer	0.00703	0.0165	CbGeAlD
Glycine—SHMT2—gonad—testicular cancer	0.00701	0.0165	CbGeAlD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.00664	0.02	CbGpPWpGaD
Glycine—GSS—seminal vesicle—testicular cancer	0.00664	0.0156	CbGeAlD
Glycine—GARS—female gonad—testicular cancer	0.00655	0.0154	CbGeAlD
Glycine—Acidosis—Ifosfamide—testicular cancer	0.00639	0.0284	CcSEcCtD
Glycine—SHMT1—gonad—testicular cancer	0.00639	0.015	CbGeAlD
Glycine—ALAS1—testis—testicular cancer	0.00638	0.015	CbGeAlD
Glycine—GATM—female gonad—testicular cancer	0.00622	0.0146	CbGeAlD
Glycine—GLDC—lymph node—testicular cancer	0.00583	0.0137	CbGeAlD
Glycine—GARS—testis—testicular cancer	0.00581	0.0137	CbGeAlD
Glycine—GRIN2C—testis—testicular cancer	0.00572	0.0134	CbGeAlD
Glycine—SHMT2—female gonad—testicular cancer	0.0057	0.0134	CbGeAlD
Glycine—GATM—testis—testicular cancer	0.00552	0.013	CbGeAlD
Glycine—SLC36A1—gonad—testicular cancer	0.00545	0.0128	CbGeAlD
Glycine—SLC6A9—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.0053	0.016	CbGpPWpGaD
Glycine—SLC6A5—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.0053	0.016	CbGpPWpGaD
Glycine—GCAT—lymph node—testicular cancer	0.00528	0.0124	CbGeAlD
Glycine—SHMT1—female gonad—testicular cancer	0.00519	0.0122	CbGeAlD
Glycine—SLC36A1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00509	0.0153	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—INSL3—testicular cancer	0.00506	0.0152	CbGpPWpGaD
Glycine—SHMT2—testis—testicular cancer	0.00506	0.0119	CbGeAlD
Glycine—Fluid overload—Cisplatin—testicular cancer	0.00491	0.0218	CcSEcCtD
Glycine—GSS—gonad—testicular cancer	0.00479	0.0113	CbGeAlD
Glycine—GLYATL1—Biological oxidations—HPGDS—testicular cancer	0.00469	0.0142	CbGpPWpGaD
Glycine—GLYAT—Biological oxidations—HPGDS—testicular cancer	0.00469	0.0142	CbGpPWpGaD
Glycine—GLYATL2—Biological oxidations—HPGDS—testicular cancer	0.00469	0.0142	CbGpPWpGaD
Glycine—ALAS1—lymph node—testicular cancer	0.00462	0.0109	CbGeAlD
Glycine—GSS—Phase II conjugation—HPGDS—testicular cancer	0.00461	0.0139	CbGpPWpGaD
Glycine—SHMT1—testis—testicular cancer	0.0046	0.0108	CbGeAlD
Glycine—SLC32A1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00451	0.0136	CbGpPWpGaD
Glycine—GLRA2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00451	0.0136	CbGpPWpGaD
Glycine—GLRA3—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00451	0.0136	CbGpPWpGaD
Glycine—SLC36A1—female gonad—testicular cancer	0.00443	0.0104	CbGeAlD
Glycine—GARS—lymph node—testicular cancer	0.00421	0.0099	CbGeAlD
Glycine—GATM—lymph node—testicular cancer	0.004	0.0094	CbGeAlD
Glycine—GRIN2A—testis—testicular cancer	0.00395	0.00928	CbGeAlD
Glycine—SLC36A1—testis—testicular cancer	0.00393	0.00922	CbGeAlD
Glycine—GSS—female gonad—testicular cancer	0.0039	0.00916	CbGeAlD
Glycine—GLRB—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00367	0.0111	CbGpPWpGaD
Glycine—SHMT2—lymph node—testicular cancer	0.00366	0.00861	CbGeAlD
Glycine—SLC16A10—gonad—testicular cancer	0.00351	0.00825	CbGeAlD
Glycine—GSS—testis—testicular cancer	0.00346	0.00812	CbGeAlD
Glycine—Salivary hypersecretion—Ifosfamide—testicular cancer	0.00344	0.0153	CcSEcCtD
Glycine—GLRB—lymph node—testicular cancer	0.00343	0.00807	CbGeAlD
Glycine—SHMT1—lymph node—testicular cancer	0.00334	0.00784	CbGeAlD
Glycine—Coma—Ifosfamide—testicular cancer	0.00323	0.0144	CcSEcCtD
Glycine—Cardiovascular disorder—Etoposide—testicular cancer	0.00318	0.0141	CcSEcCtD
Glycine—Pain—Carboplatin—testicular cancer	0.00317	0.0141	CcSEcCtD
Glycine—SLC16A10—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.0031	0.00933	CbGpPWpGaD
Glycine—Angina pectoris—Vinblastine—testicular cancer	0.003	0.0133	CcSEcCtD
Glycine—Thrombophlebitis—Ifosfamide—testicular cancer	0.00297	0.0132	CcSEcCtD
Glycine—Polyuria—Ifosfamide—testicular cancer	0.00293	0.013	CcSEcCtD
Glycine—GLRA1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.0029	0.00875	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—INSL3—testicular cancer	0.00286	0.00861	CbGpPWpGaD
Glycine—SLC36A1—lymph node—testicular cancer	0.00285	0.00669	CbGeAlD
Glycine—GARS—Gene Expression—DNMT3L—testicular cancer	0.00284	0.00857	CbGpPWpGaD
Glycine—GSS—Biological oxidations—HPGDS—testicular cancer	0.0027	0.00813	CbGpPWpGaD
Glycine—Encephalopathy—Methotrexate—testicular cancer	0.00261	0.0116	CcSEcCtD
Glycine—GPR18—Signaling by GPCR—INSL3—testicular cancer	0.00259	0.00782	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00259	0.0078	CbGpPWpGaD
Glycine—SLC16A10—testis—testicular cancer	0.00253	0.00595	CbGeAlD
Glycine—Polyuria—Cisplatin—testicular cancer	0.00252	0.0112	CcSEcCtD
Glycine—GSS—lymph node—testicular cancer	0.0025	0.00589	CbGeAlD
Glycine—Urinary retention—Ifosfamide—testicular cancer	0.00244	0.0108	CcSEcCtD
Glycine—Lung disorder—Methotrexate—testicular cancer	0.00237	0.0105	CcSEcCtD
Glycine—Hyponatraemia—Cisplatin—testicular cancer	0.00222	0.00987	CcSEcCtD
Glycine—Lung disorder—Epirubicin—testicular cancer	0.00221	0.00982	CcSEcCtD
Glycine—Angina pectoris—Ifosfamide—testicular cancer	0.00216	0.0096	CcSEcCtD
Glycine—Dehydration—Cisplatin—testicular cancer	0.00206	0.00914	CcSEcCtD
Glycine—Lung disorder—Doxorubicin—testicular cancer	0.00205	0.00909	CcSEcCtD
Glycine—Convulsion—Chlorambucil—testicular cancer	0.00203	0.00899	CcSEcCtD
Glycine—Vertigo—Vinblastine—testicular cancer	0.00193	0.00855	CcSEcCtD
Glycine—Chills—Bleomycin—testicular cancer	0.00187	0.00828	CcSEcCtD
Glycine—Convulsion—Vinblastine—testicular cancer	0.00186	0.00824	CcSEcCtD
Glycine—SLC16A10—lymph node—testicular cancer	0.00183	0.00431	CbGeAlD
Glycine—Cardiovascular disorder—Epirubicin—testicular cancer	0.00178	0.00791	CcSEcCtD
Glycine—Chills—Dactinomycin—testicular cancer	0.00174	0.00772	CcSEcCtD
Glycine—BAAT—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.00172	0.00518	CbGpPWpGaD
Glycine—Visual impairment—Ifosfamide—testicular cancer	0.00171	0.0076	CcSEcCtD
Glycine—Cardiovascular disorder—Doxorubicin—testicular cancer	0.00165	0.00732	CcSEcCtD
Glycine—Pain—Chlorambucil—testicular cancer	0.00163	0.00724	CcSEcCtD
Glycine—Chills—Ifosfamide—testicular cancer	0.00159	0.00708	CcSEcCtD
Glycine—SLC16A10—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00157	0.00474	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—INSL3—testicular cancer	0.00153	0.00462	CbGpPWpGaD
Glycine—Coma—Methotrexate—testicular cancer	0.00153	0.00679	CcSEcCtD
Glycine—Salivary hypersecretion—Epirubicin—testicular cancer	0.00152	0.00675	CcSEcCtD
Glycine—Urticaria—Chlorambucil—testicular cancer	0.00152	0.00673	CcSEcCtD
Glycine—Pain—Vinblastine—testicular cancer	0.0015	0.00664	CcSEcCtD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.00148	0.00447	CbGpPWpGaD
Glycine—Oedema—Bleomycin—testicular cancer	0.00148	0.00656	CcSEcCtD
Glycine—Visual impairment—Cisplatin—testicular cancer	0.00148	0.00655	CcSEcCtD
Glycine—Vision blurred—Ifosfamide—testicular cancer	0.00146	0.00647	CcSEcCtD
Glycine—Coma—Epirubicin—testicular cancer	0.00143	0.00635	CcSEcCtD
Glycine—Salivary hypersecretion—Doxorubicin—testicular cancer	0.00141	0.00625	CcSEcCtD
Glycine—Hypersensitivity—Chlorambucil—testicular cancer	0.00141	0.00624	CcSEcCtD
Glycine—Thrombophlebitis—Methotrexate—testicular cancer	0.0014	0.00623	CcSEcCtD
Glycine—Vertigo—Ifosfamide—testicular cancer	0.00139	0.00617	CcSEcCtD
Glycine—Polyuria—Methotrexate—testicular cancer	0.00138	0.00614	CcSEcCtD
Glycine—Hypotension—Bleomycin—testicular cancer	0.00138	0.00613	CcSEcCtD
Glycine—Oedema—Dactinomycin—testicular cancer	0.00138	0.00611	CcSEcCtD
Glycine—Convulsion—Ifosfamide—testicular cancer	0.00134	0.00595	CcSEcCtD
Glycine—Coma—Doxorubicin—testicular cancer	0.00132	0.00588	CcSEcCtD
Glycine—Thrombophlebitis—Epirubicin—testicular cancer	0.00131	0.00583	CcSEcCtD
Glycine—Diarrhoea—Chlorambucil—testicular cancer	0.00131	0.0058	CcSEcCtD
Glycine—Hypersensitivity—Vinblastine—testicular cancer	0.00129	0.00572	CcSEcCtD
Glycine—Visual disturbance—Methotrexate—testicular cancer	0.00128	0.00569	CcSEcCtD
Glycine—Pain—Bleomycin—testicular cancer	0.00126	0.00561	CcSEcCtD
Glycine—Oedema—Ifosfamide—testicular cancer	0.00126	0.0056	CcSEcCtD
Glycine—Chills—Etoposide—testicular cancer	0.00126	0.00559	CcSEcCtD
Glycine—Vision blurred—Cisplatin—testicular cancer	0.00126	0.00558	CcSEcCtD
Glycine—Thrombophlebitis—Doxorubicin—testicular cancer	0.00122	0.00539	CcSEcCtD
Glycine—Vomiting—Chlorambucil—testicular cancer	0.00121	0.00539	CcSEcCtD
Glycine—Diarrhoea—Vinblastine—testicular cancer	0.0012	0.00531	CcSEcCtD
Glycine—Back pain—Etoposide—testicular cancer	0.00118	0.00525	CcSEcCtD
Glycine—Hypotension—Ifosfamide—testicular cancer	0.00118	0.00524	CcSEcCtD
Glycine—Pain—Dactinomycin—testicular cancer	0.00118	0.00523	CcSEcCtD
Glycine—Urticaria—Bleomycin—testicular cancer	0.00117	0.00521	CcSEcCtD
Glycine—Dizziness—Vinblastine—testicular cancer	0.00116	0.00513	CcSEcCtD
Glycine—Convulsion—Cisplatin—testicular cancer	0.00116	0.00513	CcSEcCtD
Glycine—Hyponatraemia—Epirubicin—testicular cancer	0.00114	0.00507	CcSEcCtD
Glycine—Nausea—Chlorambucil—testicular cancer	0.00113	0.00503	CcSEcCtD
Glycine—Vomiting—Vinblastine—testicular cancer	0.00111	0.00494	CcSEcCtD
Glycine—Vertigo—Etoposide—testicular cancer	0.0011	0.00487	CcSEcCtD
Glycine—Oedema—Cisplatin—testicular cancer	0.00109	0.00483	CcSEcCtD
Glycine—Hypersensitivity—Bleomycin—testicular cancer	0.00109	0.00483	CcSEcCtD
Glycine—Pain—Ifosfamide—testicular cancer	0.00108	0.00479	CcSEcCtD
Glycine—Tachycardia—Cisplatin—testicular cancer	0.00106	0.00471	CcSEcCtD
Glycine—ALAS2—Metabolism—HPGDS—testicular cancer	0.00106	0.00319	CbGpPWpGaD
Glycine—Convulsion—Etoposide—testicular cancer	0.00106	0.0047	CcSEcCtD
Glycine—Dehydration—Epirubicin—testicular cancer	0.00106	0.00469	CcSEcCtD
Glycine—Hyponatraemia—Doxorubicin—testicular cancer	0.00106	0.00469	CcSEcCtD
Glycine—Nausea—Vinblastine—testicular cancer	0.00104	0.00461	CcSEcCtD
Glycine—Hypotension—Cisplatin—testicular cancer	0.00102	0.00451	CcSEcCtD
Glycine—Hypersensitivity—Dactinomycin—testicular cancer	0.00102	0.0045	CcSEcCtD
Glycine—Urticaria—Ifosfamide—testicular cancer	0.001	0.00445	CcSEcCtD
Glycine—GARS—Gene Expression—H2AFZ—testicular cancer	0.000996	0.003	CbGpPWpGaD
Glycine—Dehydration—Doxorubicin—testicular cancer	0.000979	0.00434	CcSEcCtD
Glycine—Tachycardia—Etoposide—testicular cancer	0.000973	0.00432	CcSEcCtD
Glycine—Angina pectoris—Epirubicin—testicular cancer	0.000958	0.00425	CcSEcCtD
Glycine—Diarrhoea—Dactinomycin—testicular cancer	0.000943	0.00418	CcSEcCtD
Glycine—Vomiting—Bleomycin—testicular cancer	0.000939	0.00417	CcSEcCtD
Glycine—Hypotension—Etoposide—testicular cancer	0.000932	0.00414	CcSEcCtD
Glycine—Pain—Cisplatin—testicular cancer	0.000931	0.00413	CcSEcCtD
Glycine—Hypersensitivity—Ifosfamide—testicular cancer	0.00093	0.00413	CcSEcCtD
Glycine—Angina pectoris—Doxorubicin—testicular cancer	0.000886	0.00393	CcSEcCtD
Glycine—Nausea—Bleomycin—testicular cancer	0.000878	0.00389	CcSEcCtD
Glycine—Vomiting—Dactinomycin—testicular cancer	0.000876	0.00389	CcSEcCtD
Glycine—Diarrhoea—Ifosfamide—testicular cancer	0.000864	0.00383	CcSEcCtD
Glycine—Pain—Etoposide—testicular cancer	0.000853	0.00378	CcSEcCtD
Glycine—Dizziness—Ifosfamide—testicular cancer	0.000835	0.00371	CcSEcCtD
Glycine—Nausea—Dactinomycin—testicular cancer	0.000819	0.00363	CcSEcCtD
Glycine—Visual impairment—Methotrexate—testicular cancer	0.00081	0.0036	CcSEcCtD
Glycine—Vomiting—Ifosfamide—testicular cancer	0.000803	0.00356	CcSEcCtD
Glycine—GATM—Metabolism—HPGDS—testicular cancer	0.000803	0.00242	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—HPGDS—testicular cancer	0.000803	0.00242	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—HPGDS—testicular cancer	0.000803	0.00242	CbGpPWpGaD
Glycine—GLYAT—Metabolism—HPGDS—testicular cancer	0.000803	0.00242	CbGpPWpGaD
Glycine—Hypersensitivity—Cisplatin—testicular cancer	0.000802	0.00356	CcSEcCtD
Glycine—Urticaria—Etoposide—testicular cancer	0.000792	0.00352	CcSEcCtD
Glycine—Rhinitis—Epirubicin—testicular cancer	0.000789	0.0035	CcSEcCtD
Glycine—ALAS2—Metabolism—STK11—testicular cancer	0.00077	0.00232	CbGpPWpGaD
Glycine—BAAT—Metabolism—HPGDS—testicular cancer	0.000766	0.00231	CbGpPWpGaD
Glycine—Visual impairment—Epirubicin—testicular cancer	0.000758	0.00336	CcSEcCtD
Glycine—Chills—Methotrexate—testicular cancer	0.000754	0.00335	CcSEcCtD
Glycine—Nausea—Ifosfamide—testicular cancer	0.00075	0.00333	CcSEcCtD
Glycine—Diarrhoea—Cisplatin—testicular cancer	0.000745	0.00331	CcSEcCtD
Glycine—Hypersensitivity—Etoposide—testicular cancer	0.000735	0.00326	CcSEcCtD
Glycine—Rhinitis—Doxorubicin—testicular cancer	0.00073	0.00324	CcSEcCtD
Glycine—Back pain—Methotrexate—testicular cancer	0.000708	0.00314	CcSEcCtD
Glycine—Chills—Epirubicin—testicular cancer	0.000706	0.00313	CcSEcCtD
Glycine—Visual impairment—Doxorubicin—testicular cancer	0.000702	0.00311	CcSEcCtD
Glycine—Vomiting—Cisplatin—testicular cancer	0.000692	0.00307	CcSEcCtD
Glycine—Vision blurred—Methotrexate—testicular cancer	0.00069	0.00306	CcSEcCtD
Glycine—AGXT—Metabolism—HPGDS—testicular cancer	0.000683	0.00206	CbGpPWpGaD
Glycine—Diarrhoea—Etoposide—testicular cancer	0.000682	0.00303	CcSEcCtD
Glycine—Back pain—Epirubicin—testicular cancer	0.000663	0.00294	CcSEcCtD
Glycine—ALAS1—Metabolism—HPGDS—testicular cancer	0.000661	0.00199	CbGpPWpGaD
Glycine—Dizziness—Etoposide—testicular cancer	0.00066	0.00293	CcSEcCtD
Glycine—Vertigo—Methotrexate—testicular cancer	0.000658	0.00292	CcSEcCtD
Glycine—Chills—Doxorubicin—testicular cancer	0.000653	0.0029	CcSEcCtD
Glycine—Nausea—Cisplatin—testicular cancer	0.000647	0.00287	CcSEcCtD
Glycine—Vision blurred—Epirubicin—testicular cancer	0.000646	0.00286	CcSEcCtD
Glycine—Convulsion—Methotrexate—testicular cancer	0.000634	0.00281	CcSEcCtD
Glycine—Vomiting—Etoposide—testicular cancer	0.000634	0.00281	CcSEcCtD
Glycine—Vertigo—Epirubicin—testicular cancer	0.000615	0.00273	CcSEcCtD
Glycine—Back pain—Doxorubicin—testicular cancer	0.000613	0.00272	CcSEcCtD
Glycine—Vision blurred—Doxorubicin—testicular cancer	0.000597	0.00265	CcSEcCtD
Glycine—Convulsion—Epirubicin—testicular cancer	0.000594	0.00263	CcSEcCtD
Glycine—Nausea—Etoposide—testicular cancer	0.000592	0.00263	CcSEcCtD
Glycine—GATM—Metabolism—STK11—testicular cancer	0.000583	0.00176	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—STK11—testicular cancer	0.000583	0.00176	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—STK11—testicular cancer	0.000583	0.00176	CbGpPWpGaD
Glycine—GLYAT—Metabolism—STK11—testicular cancer	0.000583	0.00176	CbGpPWpGaD
Glycine—AGXT2—Metabolism—HPGDS—testicular cancer	0.00058	0.00175	CbGpPWpGaD
Glycine—Vertigo—Doxorubicin—testicular cancer	0.000569	0.00253	CcSEcCtD
Glycine—Oedema—Epirubicin—testicular cancer	0.000559	0.00248	CcSEcCtD
Glycine—Hypotension—Methotrexate—testicular cancer	0.000558	0.00248	CcSEcCtD
Glycine—BAAT—Metabolism—STK11—testicular cancer	0.000556	0.00168	CbGpPWpGaD
Glycine—Convulsion—Doxorubicin—testicular cancer	0.000549	0.00244	CcSEcCtD
Glycine—Tachycardia—Epirubicin—testicular cancer	0.000546	0.00242	CcSEcCtD
Glycine—Hypotension—Epirubicin—testicular cancer	0.000522	0.00232	CcSEcCtD
Glycine—Oedema—Doxorubicin—testicular cancer	0.000517	0.0023	CcSEcCtD
Glycine—Pain—Methotrexate—testicular cancer	0.000511	0.00227	CcSEcCtD
Glycine—Tachycardia—Doxorubicin—testicular cancer	0.000505	0.00224	CcSEcCtD
Glycine—AGXT—Metabolism—STK11—testicular cancer	0.000496	0.0015	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—H2AFZ—testicular cancer	0.000491	0.00148	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—STK11—testicular cancer	0.000488	0.00147	CbGpPWpGaD
Glycine—Hypotension—Doxorubicin—testicular cancer	0.000483	0.00214	CcSEcCtD
Glycine—ALAS1—Metabolism—STK11—testicular cancer	0.00048	0.00145	CbGpPWpGaD
Glycine—Pain—Epirubicin—testicular cancer	0.000478	0.00212	CcSEcCtD
Glycine—Urticaria—Methotrexate—testicular cancer	0.000475	0.00211	CcSEcCtD
Glycine—SHMT1—Metabolism—HPGDS—testicular cancer	0.000473	0.00143	CbGpPWpGaD
Glycine—GSS—Metabolism—HPGDS—testicular cancer	0.000461	0.00139	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KITLG—testicular cancer	0.000451	0.00136	CbGpPWpGaD
Glycine—Urticaria—Epirubicin—testicular cancer	0.000444	0.00197	CcSEcCtD
Glycine—Pain—Doxorubicin—testicular cancer	0.000442	0.00196	CcSEcCtD
Glycine—Hypersensitivity—Methotrexate—testicular cancer	0.00044	0.00195	CcSEcCtD
Glycine—AGXT2—Metabolism—STK11—testicular cancer	0.000422	0.00127	CbGpPWpGaD
Glycine—SHMT1—Disease—H2AFZ—testicular cancer	0.000413	0.00124	CbGpPWpGaD
Glycine—Hypersensitivity—Epirubicin—testicular cancer	0.000412	0.00183	CcSEcCtD
Glycine—Urticaria—Doxorubicin—testicular cancer	0.000411	0.00182	CcSEcCtD
Glycine—Diarrhoea—Methotrexate—testicular cancer	0.000409	0.00181	CcSEcCtD
Glycine—Dizziness—Methotrexate—testicular cancer	0.000395	0.00175	CcSEcCtD
Glycine—Diarrhoea—Epirubicin—testicular cancer	0.000383	0.0017	CcSEcCtD
Glycine—Hypersensitivity—Doxorubicin—testicular cancer	0.000381	0.00169	CcSEcCtD
Glycine—SHMT1—Disease—KITLG—testicular cancer	0.00038	0.00114	CbGpPWpGaD
Glycine—Vomiting—Methotrexate—testicular cancer	0.00038	0.00169	CcSEcCtD
Glycine—Dizziness—Epirubicin—testicular cancer	0.00037	0.00164	CcSEcCtD
Glycine—Vomiting—Epirubicin—testicular cancer	0.000355	0.00158	CcSEcCtD
Glycine—Nausea—Methotrexate—testicular cancer	0.000355	0.00157	CcSEcCtD
Glycine—Diarrhoea—Doxorubicin—testicular cancer	0.000354	0.00157	CcSEcCtD
Glycine—SHMT1—Metabolism—STK11—testicular cancer	0.000344	0.00104	CbGpPWpGaD
Glycine—Dizziness—Doxorubicin—testicular cancer	0.000342	0.00152	CcSEcCtD
Glycine—GPR18—Signaling Pathways—FGFR3—testicular cancer	0.000335	0.00101	CbGpPWpGaD
Glycine—GSS—Metabolism—STK11—testicular cancer	0.000335	0.00101	CbGpPWpGaD
Glycine—Nausea—Epirubicin—testicular cancer	0.000332	0.00147	CcSEcCtD
Glycine—Vomiting—Doxorubicin—testicular cancer	0.000329	0.00146	CcSEcCtD
Glycine—GPR18—Signaling Pathways—KIT—testicular cancer	0.000308	0.000928	CbGpPWpGaD
Glycine—Nausea—Doxorubicin—testicular cancer	0.000307	0.00136	CcSEcCtD
Glycine—SHMT1—Disease—FGFR3—testicular cancer	0.000282	0.000851	CbGpPWpGaD
Glycine—SHMT1—Disease—KIT—testicular cancer	0.000259	0.000781	CbGpPWpGaD
